Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02427256
Other study ID # TOPCON-SP-1P-US-0002
Secondary ID
Status Completed
Phase
First received
Last updated
Start date February 2015
Est. completion date February 2015

Study information

Verified date June 2022
Source Topcon Corporation
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The primary objective of this clinical study is to collect additional clinical data to support an FDA 510(k) submission for the Topcon Specular Microscope SP-1P. The secondary objective is to evaluate any adverse events found during the clinical study.


Recruitment information / eligibility

Status Completed
Enrollment 76
Est. completion date February 2015
Est. primary completion date February 2015
Accepts healthy volunteers No
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria - Non-Pathologic Young Adults (18-28 years old) and Non-Pathologic Adults (29-80 years old): - Male or female subjects from 18 to 80 years old who have full legal capacity to volunteer on the date the informed consent is signed; - Subjects who can follow the instructions by the clinical staff at the clinical site, and can attend examinations on the scheduled examination date; - Subjects who agree to participate in the study. Inclusion Criteria - Pathologic Adults (29-80 years old) - Male and female subjects from 29 to 80 years old who have full legal capacity to volunteer on the date the informed consent is signed; - Subjects who can follow the instructions by the clinical staff at the clinical site, and can attend examinations on the scheduled examination date; - Subjects who agree to participate in the study; - At least one eye with any of the following conditions: - History of post-op surgical trauma including Pseudophakic or Aphakic bullous keratopathy; - History of corneal transplant; - Physical injury or trauma to the cornea; - Long term Fuch's dystrophy, Guttata, or other corneal endothelial dystrophies - Keratoconus; - Long term polymethyl methacrylate PMMA contact lens use (greater than 3 years). Exclusion Criteria - Non-Pathologic Young Adults (18-28 years old) and Non Pathologic Adults (29-80 years old) - History of post-op surgical trauma including bullous keratopathy; - History of corneal transplant; - Evidence of physical injury or trauma to the cornea; - Long term Fuch's dystrophy, Guttata or other corneal endothelial dystrophies; - Keratoconus; - Long term PMMA contact lens use (greater than 3 years); - History of cataract, refractive or ocular surgical procedures that render the cornea opaque or otherwise impact its ability to be imaged using the investigational device; - Fixation problems which may prevent obtaining good quality SP-1P and CELLCHEK PLUS in either eye. Exclusion Criteria - Pathologic Adults (29-80 years old): - History of cataract, refractive or ocular surgical procedures that render the cornea opaque or otherwise impact its ability to be imaged using the investigational device; - Fixation problems which may prevent obtaining good quality SP-1P and CELLCHEK PLUS in either eye.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Topcon Specular Microscope SP-1P

Konan Specular Microscope CELLCHEK XL


Locations

Country Name City State
United States Andover Eye Associates Andover Massachusetts

Sponsors (1)

Lead Sponsor Collaborator
Topcon Medical Systems, Inc.

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Corneal endothelial cell density Single time point - 1 day
Primary Coefficient of variation of endothelial cell area Single time point - 1 day
Primary Corneal endothelial cell % hexagonality Single time point - 1 day
Primary Central corneal thickness Single time point - 1 day
See also
  Status Clinical Trial Phase
Completed NCT02276638 - Comparative Study of Specular Microscopes for Measurements of Cell Density, Coefficient of Variation and Hexagonality
Completed NCT02470793 - Technique And Results In Endothelial Keratoplasty N/A
Recruiting NCT04072978 - Anterior Chamber Versus Scleral Fixated Intraocular Lens: Long-term Vision and Safety Outcomes
Completed NCT03107000 - Corneal Endothelial Cell Loss After Trabeculectomy Versus Phakotrabeculectomy N/A
Not yet recruiting NCT05522842 - Corneal Endothelium in Diabetics Undergoing Phacoemulsification
Completed NCT02128113 - RTA 408 Ophthalmic Suspension for the Prevention of Corneal Endothelial Cell Loss Following Cataract Surgery - GUARD Phase 2
Completed NCT05447130 - Corneal Endothelium After Phacoemulsification in Pseudo Exfoliation Syndrome N/A
Recruiting NCT03575130 - Ripasudil 0.4% Eye Drops in Fuchs Endothelial Corneal Dystrophy Phase 2
Completed NCT06396156 - Anterior Versus Posterior Artisan Intraocular Lens Fixation in Aphakic Children With Insufficient Capsular Support. N/A
Withdrawn NCT03361709 - Effect of Intracameral Dexamethasone After Phacoemulsification in Diabetics on Corneal Endothelial Cell Density Phase 4
Completed NCT02138266 - Comparative Study of Specular Microscopes for Endothelial and Corneal Cell Measurements
Completed NCT04396301 - Effect of Intracameral Injection of Mydriatic Plus Anaesthetic Combination on Corneal Endothelial Count in Phaco Phase 3
Recruiting NCT05847387 - The Viability Control of Human Endothelial Cells Before Keratoplasty (V-CHECK) Study
Recruiting NCT05119270 - Comparison of Phacoemulsification and Corneal Damage Between FLACS and Standard Phaco With Two Handpieces N/A
Recruiting NCT01726790 - Effect of Intravitreal Bevacizumab on Corneal Endothelium N/A